Skip to main content
Shannon Blalock, MD, Pediatric Cardiology, Dallas, TX

ShannonElizabethBlalockMD

Pediatric Cardiology Dallas, TX

Medical Director, Pediatric Cardiology East Texas, Children’s Medical Center

Overview of Dr. Blalock

Dr. Shannon Blalock is a pediatric cardiologist in Dallas, TX and is affiliated with multiple hospitals in the area, including Children's Medical Center Dallas, Texas Health Presbyterian Hospital Flower Mound, Medical City Dallas, and Medical City Lewisville. She received her medical degree from Texas AM Health Science Center College of Medicine and has been in practice 15 years. She is one of 88 doctors at Children's Medical Center Dallas and one of 20 doctors at Texas Health Presbyterian Hospital Flower Mound who specialize in Pediatric Cardiology. She has more than 10 publications and over 250 citings.

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Pediatric Cardiology, 2005 - 2008
  • University of Arkansas for Medical Sciences (UAMS) College of Medicine
    University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Pediatrics, 2002 - 2005
  • Texas A&M; Health Science Center College of Medicine
    Texas A&M; Health Science Center College of MedicineClass of 2002

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2005 - 2025
  • American Board of Pediatrics Pediatric Cardiology

Publications & Presentations

PubMed

Press Mentions

  • jCyte Announces Expansion of Role for Chief Commercial Officer Samir Mody
    jCyte Announces Expansion of Role for Chief Commercial Officer Samir ModyOctober 14th, 2021
  • A Pfizer Partner Welcomes Ex-ADC Therapeutics CMO Jay Feingold to the Team; Amid Tough Sledding, Immunovant Chooses Eli Lilly Alum as CFO
    A Pfizer Partner Welcomes Ex-ADC Therapeutics CMO Jay Feingold to the Team; Amid Tough Sledding, Immunovant Chooses Eli Lilly Alum as CFOSeptember 17th, 2021
  • Great Danes: Two Nordic Biotechs Name Their Chief Executives; Axel Hoos Bids Adieu to GlaxoSmithKline, Becomes CEO of Small Oncology Player
    Great Danes: Two Nordic Biotechs Name Their Chief Executives; Axel Hoos Bids Adieu to GlaxoSmithKline, Becomes CEO of Small Oncology PlayerJuly 9th, 2021
  • Join now to see all